Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BXRX
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Baudax Bio Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 435.93K
- Ent value
- 30.89M
- Price/Sales
- 1.34
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -98.63%
- 3 year return
- -92.03%
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
BXRX does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | 0.07 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.34 |
| Price to Book | - |
| EV to Sales | 94.77 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 43.59M |
| EPS (TTM) | -0.90 |
| FCF per share (TTM) | 0.73 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 326.00K |
| Gross profit (TTM) | -5.02M |
| Operating income (TTM) | -22.11M |
| Net income (TTM) | -7.15M |
| EPS (TTM) | -0.90 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -1539.26% |
| Operating margin (TTM) | -6781.90% |
| Profit margin (TTM) | -2194.48% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 363.00K |
| Net receivables | 0.00 |
| Total current assets | 1.34M |
| Goodwill | 8.80M |
| Intangible assets | 3.90M |
| Property, plant and equipment | 7.07M |
| Total assets | 20.58M |
| Accounts payable | 7.82M |
| Short/Current long term debt | 8.10M |
| Total current liabilities | 19.05M |
| Total liabilities | 30.82M |
| Shareholder's equity | -10.24M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -14.31M |
| Capital expenditures (TTM) | 40.00K |
| Free cash flow (TTM) | 5.82M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -34.76% |
| Return on Invested Capital | 153.22% |
| Cash Return on Invested Capital | -124.57% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| BXRX | S&P500 | |
| Current price drop from All-time high | -99.99% | -3.47% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 2 May 2024 | 9 Mar 2009 |
| Avg drop from high | -85.90% | -11.07% |
| Avg time to new high | 112 days | 12 days |
| Max time to new high | 1068 days | 1805 days |
COMPANY DETAILS
Marketcap
435.93K
Marketcap category
Small-cap
Description
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.
Employees
9
Website
Investor relations
-
SEC filings
CEO
Gerri A. Henwood
Country
USA
City
Malvern
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner